At a Glance
Atlas Venture is a venture capital firm based in Cambridge, MA founded in 1980. Thirty years at the leading-edge of medical innovation and we’re just getting started. The firm focuses on Seed, Series A investments across sectors including Biotech. The firm manages $3B in assets under management. Notable portfolio companies include Fulcrum Therapeutics, Relay Therapeutics, KSQ Therapeutics, Nurix Therapeutics and Tango Therapeutics. Venture creation firm building breakthrough biotech startups in partnership with exceptional entrepreneurs and scientists.
“Venture creation firm building breakthrough biotech startups in partnership with exceptional entrepreneurs and scientists.”
Atlas Venture primarily invests at the Seed, Series A stages. This means they focus on companies that are building their initial product and finding product-market fit.
Atlas Venture is headquartered in Cambridge, MA. Many of their portfolio companies are also based in this region, though they invest across geographies.
Atlas Venture focuses on investments in Biotech. Their portfolio reflects deep expertise and networks within these sectors.
Atlas Venture's typical investment check size ranges from $500K to $1M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Atlas Venture manages approximately $3B in assets under management (AUM) across their funds.
